Navigation Links
Essilor : 2009 First Quarter Report
Date:4/22/2009

1% +2.4% Latin America 27.8 28.3 -1.9% +10.2% - Satisloh 24.4** - - - - *Of which 3.2% due to the consolidation of Satisloh **Excluding EUR7.7 million in revenue from sales to Essilor

Growth in Europe was dampened by the decline in instrument sales and the very challenging economic conditions in the United Kingdom, Spain, Italy and certain Eastern European countries. By leveraging the multi-network strategy, operations in France and Germany held business firm during the period, while market share gains drove very strong growth in Russia.

In the United States, sales from the prescription laboratory network to independent eyecare professionals held up well during the quarter, but business with certain optical chains was more difficult.

Emerging markets in Asia continued to enjoy very strong growth in revenue, especially in India. Operations in Australia also reported sustained momentum. On the other hand, sales in Japan declined in a persistently difficult market.

Lastly, Essilor maintained its robust expansion in Latin America, led by operations in Brazil and Mexico.

In the optical equipment business, Satisloh is facing weaker demand from prescription laboratories in the machines segment, primarily in Europe.

First-quarter highlights

Essilor raised its stake in JZO, the ophthalmic optics market leader in Poland and a BBGR distributor, to 51% from 10% previously. JZO reported EUR15.5 million in revenue in 2008 and has more than 300 employees. The increased stake will enable Essilor to leverage the fast growth in progressive lenses in Poland, the Ukraine and Lithuania, where JZO has distribution subsidiaries.

In India, Essilor raised its interest in GKB Rx Lens Private Ltd from 50% to 60%. Based in Kolkata, GKB Rx Lens Private Ltd oper
'/>"/>

SOURCE Essilor
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Essilor Cancels 1,600,000 Shares
2. Essilor Finalizes Satisloh Agreement
3. Essilors First-Half 2008 Results
4. Essilor : Nomination of Hubert Sagnieres
5. Essilor: New Acquisitions in the United States and Brazil
6. Essilor Cancels 700,000 Shares
7. Essilors 2007 Third-Quarter Report
8. Human Genome Sciences to Sponsor Conference Call to Discuss First Quarter 2009 Financial Results
9. Sangamo BioSciences Announces First Quarter 2009 Conference Call and Webcast
10. ViroPharma to Release 2009 First Quarter Financial Results on April 29, 2009
11. SiliconSky GPS Designs First AGPS-Enabled Asthma Inhaler for Landmark Research Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... 15 AstraZeneca (NYSE: ... (UVa) in Charlottesville, today announced that they ... to enhance development of new treatments primarily ... secondary focus on peripheral vascular disease (PAD). ... The collaborative preclinical research projects will focus ...
(Date:12/15/2009)... MANOR, N.Y., Dec. 15 The International ... that the professional society is continuing to accept ... being held in Arlington, VA, April 19-21, 2010. ... is encouraging non-members to join the organization to ... The submission deadline is 12 AM EST, January ...
(Date:12/15/2009)... and LONDON, Dec. 15 ... Thomson Pharma ® has become the first drug ... protocol and outcome information. This highly anticipated new ... customers this month. ,, Thomson ... intelligence from registries, publications, press releases, conferences, and ...
(Date:12/14/2009)... and THOUSAND OAKS, Calif., Dec. 14 ... Amgen Inc.(Nasdaq: AMGN ) today announced that ... worldwide rights to Array,s small-molecule glucokinase activator program, ... 1 clinical trial in patients with Type 2 ... the agreement, Array will receive an upfront payment ...
Breaking Biology Technology:AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 2AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 3The International Society for Medical Publication Professionals Announces Call for Abstracts for Its 6th Annual Meeting 2The International Society for Medical Publication Professionals Announces Call for Abstracts for Its 6th Annual Meeting 3Thomson Reuters is First to Offer Fully Integrated Pipeline and Clinical Trials 2Array BioPharma and Amgen Partner in Type 2 Diabetes 2Array BioPharma and Amgen Partner in Type 2 Diabetes 3Array BioPharma and Amgen Partner in Type 2 Diabetes 4Array BioPharma and Amgen Partner in Type 2 Diabetes 5Array BioPharma and Amgen Partner in Type 2 Diabetes 6Array BioPharma and Amgen Partner in Type 2 Diabetes 7
... Claire, Wis. When Suzanne DeCann visits the University ... May, it will be to pick up her newly earned ... Georgia, will be among the first 11 UW-Eau Claire students ... Eau Claire for commencement, shell get her first real look ...
... announced Saturday it will feature its carbon dioxide-cooled Jeep ... Cedar Rapids, Iowa, May 3-5. This vehicle features an ... emissions, cools faster than current systems and is more ... of space under the hood. , ,Carbon dioxide is ...
... NameProtect has announced a new version of its online ... are showing up in search-engine ads. , ,NameProtects search tools ... are not already taken, or that their trademarks are not ... monitors search-engine ads daily and watches for trademarks that other ...
Other Biology Technology:UW-Eau Claire graduates first online MBAs 2UW-Eau Claire graduates first online MBAs 3
(Date:12/15/2009)... December 2009 - Scientists at VIB and Ghent University ... the treatment of septic shock, the major cause of ... of nitric oxide (NO) gas in mice with septic ... the animal,s organs showed much less damage, while their ... expectations, since it is generally assumed that nitric oxide ...
(Date:12/15/2009)... of Spanish and American researchers found the fossil remains of ... they have published, for the first time, the results of ... of the young cetacean, possibly a baleen whale from the ... the partial fossil remains of a whale from the Lower ... formation, but it is the first time that the results ...
(Date:12/15/2009)... Rip currents exact an enormous emotional and economic toll on ... drown in rip currents each year in U.S. waters and ... thousand deaths worldwide. A serious disconnect exists between rip ... confused with rip tides and undertows, and more importantly, most ... escape, from a rip current. , The goal of the ...
Breaking Biology News(10 mins):Septic shock: Nitric oxide beneficial after all 2Story of 4.5 million-year-old whale unveiled in Huelva 2Story of 4.5 million-year-old whale unveiled in Huelva 3Jack LaLanne Celebrated as Fitness Icon at Star Studded Birthday Bash 59465 1Jack LaLanne Celebrated as Fitness Icon at Star Studded Birthday Bash 59465 2Quantel Signs a Distribution Agreement With US based National Biological 14471 1Quantel Signs a Distribution Agreement With US based National Biological 14471 2Global Vision Helps First Priority Reduce Costs in Tough Times 5476 1Global Vision Helps First Priority Reduce Costs in Tough Times 5476 2
... November 20, 2007 SAGE and the Hindawi Publishing ... launch and publish a suite of fully Open Access ... that places SAGE as the largest academic publisher to ... the companys continued investment in widening access to important ...
... such as malaria and dengue cause suffering and death ... one million deaths annually, and is particularly devastating in ... to the human toll, these diseases consume vast economic ... it. Various approaches to controlling these diseases such ...
... in reprogramming skin cells to behave like embryonic stem ... ethical dynamics of the stem-cell debate, a leading bioethicist ... bioethics, says the scientific finding could have far-reaching effects ... embryonic stem cell research., , "This is a method for ...
Other Biology News:SAGE and Hindawi announce landmark open access agreement 2Selfish DNA and the Genetic Control of Vector-Borne Diseases 2Selfish DNA and the Genetic Control of Vector-Borne Diseases 3Reprogramming the debate: stem-cell finding alters ethical controversy 2Reprogramming the debate: stem-cell finding alters ethical controversy 3
... one plate. The new ArraySlide 96 chamber ... x 7mm) individual printing surfaces for multiple ... studies. Unlike other systems, this device utilizes ... of contaminating adhesives. The chamber itself is ...
... System is an automated multiplexing platform that ... detection, pathogen sequence detection and pharmacogenetics applications. ... applied to an open and flexible electronic ... reused until all tests sites have been ...
... siTrio siRNA --- a cocktail of 3 ... of interestis our most popular product. The ... 75% knockdown of your target gene when ... for transfection and confirmation of optimal transfection ...
... offers a large collection of phage ... tissuea, cell lines, and mouse tissues. ... pHD9 vector. The size of cDNA ... from 200bp to 1000bp by gel ...
Biology Products: